What is the Vivanza Biosciences Ltd share price today?

The share price of BSE:VIVANZA-X on 07 Sep 2026 (as of 11:02:52 IST) is ₹1.70.

What is the BSE:VIVANZA-X 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the BSE:VIVANZA-X 52 week high low range shows a high of ₹2.72 and a low of ₹1.52.

What is the Vivanza Biosciences Ltd market cap?

As on 07 Sep 2026, Vivanza Biosciences Ltd market cap is ₹7.00 Cr.

What is the shareholding pattern of Vivanza Biosciences Ltd Stock?

The shareholding pattern of Vivanza Biosciences Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 20.02% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 79.98% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Vivanza Biosciences Ltd?

The Price-to-Earnings (PE) ratio of Vivanza Biosciences Ltd is 15.42, and the Price-to-Book (PB) ratio is 1.62, as on 07 Sep 2026.

Vivanza Biosciences Share Price

1.76-0.04 (-2.22%)

-15.79% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-2.22%

1 Week

+0.00%

1 Month

+1.73%

3 Month

-12.00%

6 Month

-2.22%

YTD

-20.00%

1 Year

-15.79%

5 Year

-86.95%

10 Year

Max

+5.07%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

1.75

1.70

1.65

1.52

High

1.80

1.89

1.97

2.00

2.15

2.72

About

Vivanza Biosciences Ltd was Incrporated in the year of 1982. The company is in the business activity of Trading Of Pharmaceutical Products. The company's range of products and services include Read more

Trading

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

ADANIENT-ANSE

AEGISLOG-ANSE

CPPLUS-ANSE

PREMIERENE-ANSE

REDINGTON-ANSE

HONASA-ANSE

LLOYDSENT-ANSE

CELLO-ANSE

JSLL-ANSE

SREEL-TNSE

VIVANZA-XNSE

LTP

1W Low

1W High

Market cap (₹)

2920-79.1 (-2.64%)

2900

3025

4,04,763Cr

1373.5-43.75 (-3.09%)

1347.50

1528

49,337Cr

3798.85+447 (13.34%)

3344.30

3875.70

45,264Cr

898-5 (-0.55%)

885.10

919.30

41,326Cr

406.45+6.75 (1.69%)

390.60

419.55

31,353Cr

475.35-4.25 (-0.89%)

466

491.75

15,804Cr

75.52+6.73 (9.78%)

67.25

77.10

11,326Cr

340.15+17.6 (5.46%)

314.90

344.10

7,311Cr

511.55+1.9 (0.37%)

505

530.50

6,517Cr

299.95+13.15 (4.59%)

266.60

305

673Cr

1.76+0 (0.00%)

1.75

1.89

7Cr

Vivanza Biosciences Share Price

1.76-0.04 (-2.22%)

-15.79% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years64%

3 years87%

Last year1461%

Compounded Profit Growth

10 years-

5 years39%

3 years-13%

Last year159%

Stock Price CAGR

10 years-

5 years-33%

3 years-46%

1 year-14%

Return on Equity

10 years0%

5 years6%

3 years2%

Last year9%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	64%	87%	1461%
-	39%	-13%	159%
-	-33%	-46%	-14%
0%	6%	2%	9%

Peer Comparison

Symbol

ADANIENT-A

AEGISLOG-A

CPPLUS-A

PREMIERENE-A

REDINGTON-A

HONASA-A

LLOYDSENT-A

CELLO-A

JSLL-A

SREEL-T

VIVANZA-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
2,920	₹404763 Cr	54.37	-8.91	105.06	₹9339 Cr
1,373.5	₹49337 Cr	39.43	13.8	41.65	₹898 Cr
3,798.85	₹45264 Cr	94.84	12.07	45.29	₹368 Cr
898	₹41326 Cr	24.82	10.2	45.28	₹1510 Cr
406.45	₹31353 Cr	18.43	6.22	24.36	₹1490 Cr
475.35	₹15804 Cr	63.5	2.77	8.99	₹200 Cr
75.52	₹11326 Cr	100.86	0.38	0.91	₹283 Cr
340.15	₹7311 Cr	23.37	3.32	17.46	₹332 Cr
511.55	₹6517 Cr	27.56	5.31	23.32	₹222 Cr
299.95	₹673 Cr	20.51	3.02	14.74	₹29 Cr
1.76	₹7 Cr	15.86	0.04	0.12	₹39 L

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
—	—	—	—	—	—	—	—	—	—	—
₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹19 L
₹36 L	-₹4 L	₹64 L	₹9 L	-₹51 L	-₹84 L	-₹92 L	-₹71 L	-₹27 L	-₹47 L	-₹16 L
₹36 L	-₹4 L	₹64 L	₹9 L	-₹51 L	-₹84 L	-₹92 L	-₹71 L	-₹27 L	-₹47 L	-₹16 L
₹4 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹2 L
₹10 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹78 L	₹3 Cr	₹3 Cr	₹1 Cr	₹3 Cr	₹0	₹21 L	₹58 L	₹56 L	₹37 L	₹0
₹2,000	-₹6,000	-₹21,000	-₹10,000	-₹11,000	-₹3,626	₹0	₹0	₹0	₹0	₹0
₹88 L	₹3 Cr	₹3 Cr	₹1 Cr	₹3 Cr	-₹3,626	₹21 L	₹58 L	₹56 L	₹37 L	₹0
—	—	—	—	—	—	—	—	—	—	—
₹7 Cr	₹3 Cr	₹8 Cr	₹10 Cr	₹5 Cr	₹4 Cr	₹8 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹5 L
₹11 L	₹1 Cr	₹1 Cr	₹68 L	₹1 Cr	₹100 L	₹70 L	₹59 L	₹21 L	₹11 L	₹6 L
₹9 Cr	₹5 Cr	₹2 Cr	₹7 Cr	₹3 Cr	₹36 L	₹18 L	₹90 L	₹77 L	₹53 L	₹50 L
₹23 L	₹6 L	₹29 L	₹16 L	₹4 L	₹7 L	₹4 L	₹6 L	₹6 L	₹7 L	₹0
₹17 Cr	₹9 Cr	₹12 Cr	₹17 Cr	₹9 Cr	₹5 Cr	₹9 Cr	₹7 Cr	₹6 Cr	₹3 Cr	₹61 L
₹22 Cr	₹16 Cr	₹19 Cr	₹22 Cr	₹16 Cr	₹8 Cr	₹12 Cr	₹11 Cr	₹10 Cr	₹7 Cr	₹64 L
₹10 Cr	₹9 Cr	₹5 Cr	₹8 Cr	₹6 Cr	₹36 L	₹39 L	₹1 Cr	₹1 Cr	₹90 L	₹50 L
—	—	—	—	—	—	—	—	—	—	—
₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹0
₹25 L	₹23 L	₹22 L	₹21 L	₹20 L	₹20 L	₹19 L	₹19 L	₹19 L	₹19 L	₹0
₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹0
₹25,000	₹25,000	₹25,000	₹25,000	₹25,000	₹25,010	₹25,010	₹25,010	₹25,010	₹25,010	₹25,010
₹25,000	₹25,000	₹25,000	₹25,000	₹25,000	₹25,010	₹25,010	₹25,010	₹25,010	₹25,010	₹25,010
₹59 L	₹2 Cr	₹1 Cr	₹60 L	₹79 L	₹1 Cr	₹90 L	₹1 Cr	₹75 L	₹75 L	₹59 L
₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹60 L
—	—	—	—	—	—	—	—	—	—	—
₹4 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹65 L	₹97 L	₹2 Cr	₹2 Cr	₹2 Cr	₹0
₹12 Cr	₹8 Cr	₹12 Cr	₹12 Cr	₹8 Cr	₹6 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹0
₹7 L	₹12 L	₹17 L	₹14 L	₹6 L	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹2 Cr	₹3 L
₹0	₹0	₹4 L	₹7 L	₹11 L	₹35 L	₹34 L	₹43 L	₹42 L	₹19 L	₹1 L
₹3 Cr	₹2 Cr	₹2 Cr	₹4 Cr	₹2 Cr	₹85 L	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹0
₹19 Cr	₹12 Cr	₹16 Cr	₹20 Cr	₹12 Cr	₹5 Cr	₹9 Cr	₹8 Cr	₹7 Cr	₹4 Cr	₹4 L
₹2 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	-₹27 L	₹8 L	₹42 L	₹1 Cr	₹82 L	-₹57 L
₹22 Cr	₹16 Cr	₹19 Cr	₹22 Cr	₹16 Cr	₹8 Cr	₹12 Cr	₹11 Cr	₹10 Cr	₹7 Cr	₹64 L
₹1	₹1	₹1	₹1	₹9	₹8	₹8	₹8	₹9	₹9	₹1
₹1	₹1	₹1	₹1	₹1	₹8	₹8	₹8	₹9	₹9	₹1

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
₹54 L	-₹67 L	₹70 L	₹72 L	₹33 L	₹12 L	-₹21 L	-₹44 L	₹23 L	-₹31 L	₹0
₹30 L	₹37 L	₹43 L	₹42 L	₹41 L	₹48 L	₹44 L	₹42 L	₹36 L	₹9 L	₹0
-₹3 Cr	-₹2 Cr	₹1 Cr	-₹2 Cr	₹2 Cr	-₹3 Cr	₹3 Cr	₹88 L	-₹68 L	-₹2 Cr	₹0
-₹2 Cr	-₹2 Cr	₹2 Cr	-₹83 L	₹2 Cr	-₹3 Cr	₹3 Cr	₹86 L	-₹9 L	-₹2 Cr	₹0
-₹3 Cr	-₹2 Cr	₹2 Cr	-₹95 L	₹2 Cr	-₹3 Cr	₹3 Cr	₹86 L	-₹9 L	-₹2 Cr	₹0
-₹12 L	-₹79,000	-₹4 L	₹0	₹0	-₹2 L	₹0	₹0	₹0	₹2 Cr	₹0
₹3 Cr	₹2 Cr	-₹2 Cr	₹1 Cr	-₹2 Cr	₹2 Cr	-₹3 Cr	-₹89 L	-₹55 L	₹39 L	₹0
-₹5 L	-₹5 L	₹3 L	₹9 L	-₹1 L	-₹32 L	₹22 L	-₹3 L	-₹64 L	₹23 L	₹0
₹12 L	₹17 L	₹14 L	₹6 L	₹7 L	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹2 Cr	-₹3 Cr	₹0
₹7 L	₹12 L	₹17 L	₹14 L	₹6 L	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹2 Cr	₹0

Fundamental Ratios

Consolidated

Standalone

Vivanza Biosciences Share Price

1.76-0.04 (-2.22%)

-15.79% past 1 Year

Shareholding summary

Promoters

20.02%

FII

DII

Others

79.98%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
20.02%	20.02%	20.02%	20.02%	20.02%	20.02%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
79.98%	79.98%	79.98%	79.98%	79.98%	79.98%

Bulk & block deals

Name

Jagdish Lal

Raj Kumar Baid

Vishal Chinubhai Suthar Huf

Bibhas Bhagwandas Asar

Swati Vishal Suthar

Jiten Kumar Biswas

Kalpesh Vithaldas Rami

Swati Vishal Suthar

Kalpesh Vithaldas Rami

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
26 May 2025	Sell	6.45 L	₹2.45	2.63 L	Bulk	0.658465	BSE
06 Feb 2025	Sell	5.31 L	₹2.39	2.22 L	Bulk	0.555555	BSE
08 Jan 2025	Purchase	10.80 K	₹3.60	3 K	Bulk	0.0075	BSE
08 Jan 2025	Sell	38.18 L	₹3.67	10.40 L	Bulk	2.600788	BSE
08 Jan 2025	Sell	10.83 L	₹3.61	3 L	Bulk	0.75	BSE
08 Jan 2025	Sell	8.97 L	₹3.68	2.44 L	Bulk	0.609648	BSE
01 Jan 2025	Purchase	8.04 L	₹3.69	2.18 L	Bulk	0.545	BSE
27 Dec 2024	Sell	11.48 L	₹3.48	3.30 L	Bulk	0.824457	BSE
27 Dec 2024	Sell	9.22 L	₹3.49	2.64 L	Bulk	0.660523	BSE
26 Dec 2024	Purchase	11.62 L	₹3.17	3.66 L	Bulk	0.916192	BSE

Insider trading & SAST

Client name

Parth H Parikh

Parth Hemant Parikh

Parth H Parikh

Parth Hemant Parikh

Parth H Parikh

Parth Hemant Parikh

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
02 Jan 2025	Promoter	Disposal	1.03	19.8	0	—	4.12 L	17 Dec 2024	Market	79,07,622	SAST	29(2)	—
20 Dec 2024	Promoter	Disposal	3.6	20.8	0	—	14.39 L	09 Dec 2024 - 10 Dec 2024	Market	83,19,826	SAST	29(2)	—
19 Dec 2024	Promoter	Disposal	1.03051	19.8	14.84 L	₹3.60	4.12 L	17 Dec 2024	Market Sale	79,07,622	Insider Trading	—	Equity Shares
12 Dec 2024	Promoter	Disposal	0.46	24.4	0	—	1.85 L	05 Dec 2024	Market	97,58,622	SAST	29(2)	—
11 Dec 2024	Promoter	Disposal	0.41	25.05	0	—	1.65 L	02 Dec 2024	Market	1,00,21,952	SAST	29(2)	—
11 Dec 2024	Promoter	Disposal	0.2	24.86	0	—	78.18 K	04 Dec 2024	Market	99,43,776	SAST	29(2)	—
11 Dec 2024	Promoter	Disposal	1.09699	23.3	14.48 L	₹3.30	4.39 L	09 Dec 2024	Market Sale	93,19,826	Insider Trading	—	Equity Shares
11 Dec 2024	Promoter	Disposal	2.5	20.8	34.70 L	₹3.47	10 L	10 Dec 2024	Market Sale	83,19,826	Insider Trading	—	Equity Shares
10 Dec 2024	Promoter	Disposal	1.17	25.47	0	—	4.66 L	28 Nov 2024 - 29 Nov 2024	Market	1,01,87,089	SAST	29(2)	—
06 Dec 2024	Promoter	Disposal	0.462885	24.4	6.55 L	₹3.54	1.85 L	05 Dec 2024	Market Sale	97,58,622	Insider Trading	—	Equity Shares

Vivanza Biosciences Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Vivanza Biosciences Share Price

Vivanza Biosciences Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Vivanza Biosciences Share Price

Vivanza Biosciences Share Price

Oscillators

Moving averages

Vivanza Biosciences Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Vivanza Biosciences Share Price

Corporate Actions

Company details

Vivanza Biosciences Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Vivanza Biosciences Share Price

News

Vivanza Biosciences informs about board meeting

Vivanza Biosciences reports Profit after tax of Rs -26.60 Lakhs, in the March 2026 quarter

Vivanza Biosciences informs about resignation of director

Vivanza Biosciences - Quaterly Results

Vivanza Biosciences reports Profit after tax of 16.10 Lakhs, in the December 2025 quarter

Vivanza Biosciences reports Profit after tax of 46.20 Lakhs, in the September 2025 quarter

Vivanza Biosciences informs about outcome of board meeting

Vivanza Biosciences informs about board meeting

Vivanza Biosciences - Quaterly Results

Vivanza Biosciences - Quaterly Results

Vivanza Biosciences reports Profit after tax of 1.80 Lakhs, in the June 2025 quarter

Vivanza Biosciences - Quaterly Results

Vivanza Biosciences - Quaterly Results

Vivanza Biosciences reports Profit after tax of Rs -96.50 Lakhs, in the March 2025 quarter

Vivanza Biosciences - Quaterly Results

Vivanza Biosciences informs about updates

Vivanza Biosciences informs about compliance certificate

Vivanza Biosciences informs about trading window closure

Vivanza Biosciences informs about appointment of CS cum CO

Vivanza Biosciences informs about outcome of board meeting

Vivanza Biosciences Ltd Share Price Today

Vivanza Biosciences Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator